Inovio Pharmaceuticals Inc
Company & Industry Overviews
Why Sellas Life Sciences Stock Rose over 11% Today
Today, Sellas Life Sciences (SLS) announced that the FDA has assigned fast-track designation to its lead drug, GPS (galinpepimut-S), which is under development for the treatment of multiple myeloma.
How Does Novavax Compare to Its Competitors?
Novavax posted a negative EPS (earnings per share) of -$0.39 in 2Q15, which is better than its 1Q15 EPS.
How Did Novavax Perform in 2Q15?
Novavax (NVAX) posted a variety of positive qualitative and quantitative performance indicators in 2Q15.